This is a table of type proper and their frequencies. Use it to search & browse the list to learn more about your study carrel.
| proper | frequency |
|---|---|
| SARS | 389 |
| COVID-19 | 343 |
| CoV-2 | 280 |
| RSV | 189 |
| M | 169 |
| PCR | 137 |
| Table | 107 |
| ID | 91 |
| PIV | 89 |
| China | 85 |
| Health | 84 |
| CoV | 84 |
| CI | 81 |
| A | 80 |
| United | 78 |
| HIV | 77 |
| remdesivir | 76 |
| States | 74 |
| CTI | 72 |
| RT | 65 |
| HRV | 65 |
| ED | 65 |
| ICU | 62 |
| TTV | 58 |
| Coronavirus | 58 |
| RNA | 55 |
| HKU1 | 53 |
| EBV | 53 |
| PPE | 52 |
| Open | 52 |
| Forum | 52 |
| Supplementary | 51 |
| HLH | 50 |
| Hospital | 50 |
| Wuhan | 49 |
| Disease | 47 |
| Diseases | 46 |
| Infectious | 45 |
| US | 43 |
| sha | 40 |
| PUI | 40 |
| Dis | 40 |
| MP | 37 |
| C | 37 |
| H1N1 | 36 |
| MERS | 35 |
| B | 35 |
| March | 35 |
| University | 35 |
| H5N1 | 34 |
| IQR | 32 |
| Clinical | 32 |
| May | 31 |
| LPV | 31 |
| South | 31 |
| mg | 31 |
| Respiratory | 29 |
| U.S. | 28 |
| T | 28 |
| National | 28 |
| CRS | 28 |
| CDC | 28 |
| Africa | 28 |
| April | 27 |
| Latinx | 27 |
| Medical | 27 |
| Review | 26 |
| Research | 26 |
| Figure | 26 |
| DNA | 26 |
| CoV-1 | 26 |
| Center | 26 |
| American | 26 |
| New | 25 |
| LBW | 25 |
| June | 25 |
| HEV | 25 |
| February | 25 |
| HI | 24 |
| Ebola | 24 |
| IPC | 23 |
| VOMC | 23 |
| Sibu | 23 |
| IFA | 22 |
| EC | 22 |
| Department | 22 |
| Control | 22 |
| CMV | 22 |
| R | 21 |
| Prevention | 21 |
| Organization | 21 |
| Institute | 21 |
| IgG | 21 |
| Hubei | 21 |
| NAT | 20 |
| Influenza | 20 |
| NP | 20 |
| Treatment | 20 |
| SARI | 19 |
| Middle | 19 |
| Kapit | 19 |
| ICMJE | 19 |
| Form | 19 |
| East | 19 |
| Disclosure | 19 |
| Cox | 19 |
| AS | 19 |
| Use | 19 |
| Rickettsia | 18 |
| HCWs | 18 |
| COPD | 18 |
| December | 18 |
| S | 18 |
| World | 18 |
| parainfluenza | 18 |
| York | 17 |
| Laboratory | 17 |
| January | 17 |
| IMV | 17 |
| FDA | 17 |
| Epstein | 17 |
| Care | 17 |
| CAR | 17 |
| Barr | 17 |
| College | 16 |
| Guangzhou | 16 |
| J | 16 |
| Centers | 16 |
| IAV | 16 |
| FilmArray | 16 |
| Panel | 16 |
| hydroxychloroquine | 16 |
| Supplemental | 16 |
| VI | 16 |
| Patients | 16 |
| IgM | 15 |
| BMI | 15 |
| Board | 15 |
| Duke | 15 |
| FU | 15 |
| Italy | 15 |
| L | 15 |
| N | 15 |
| Remdesivir | 15 |
| Society | 15 |
| tocilizumab | 15 |
| Committee | 14 |
| ARDS | 14 |
| CCL2 | 14 |
| CD19 | 14 |
| City | 14 |
| MCP-1 | 14 |
| Drug | 14 |
| E | 14 |
| Group | 14 |
| Israel | 14 |
| SEIR | 14 |
| Institutional | 13 |
| < | 13 |
| CBER | 13 |
| CHMP | 13 |
| Dr. | 13 |
| Epidemiology | 13 |
| FiO | 13 |
| Food | 13 |
| Medicine | 13 |
| K | 13 |
| MV | 13 |
| • | 13 |
| Pandemic | 13 |
| Study | 13 |
| lymphohistiocytosis | 13 |
| post | 13 |
| AKI | 12 |
| Administration | 12 |
| Association | 12 |
| CT | 12 |
| Emergency | 12 |
| General | 12 |
| IL-6 | 12 |
| MF59 | 12 |
| Novel | 12 |
| Sarawak | 12 |
| Saudi | 12 |
| Viral | 12 |
| Wang | 12 |
| lymphopenia | 12 |
| August | 11 |
| EV | 11 |
| FRI | 11 |
| Healthcare | 11 |
| OC43 | 11 |
| Inc. | 11 |
| MF59-adjuvanted | 11 |
| IBV | 11 |
| Public | 11 |
| Wilcoxon | 11 |
| conorii | 11 |
| ddPCR | 11 |
| echovirus | 11 |
| metapneumovirus | 11 |
| Syndrome | 11 |
| Malaysia | 10 |
| AF | 10 |
| Arabia | 10 |
| Army | 10 |
| Asia | 10 |
| California | 10 |
| County | 10 |
| IgA | 10 |
| Infection | 10 |
| Human | 10 |
| Nepal | 10 |
| Program | 10 |
| Province | 10 |
| RP | 10 |
| Report | 10 |
| S. | 10 |
| SGA | 10 |
| November | 10 |
| Singapore | 10 |
| CHF | 9 |
| DIC | 9 |
| Covid-19 | 9 |
| CoV-2-specific | 9 |
| CRP | 9 |
| ASP | 9 |
| CA | 9 |
| C. | 9 |
| America | 9 |
| ALB | 9 |
| EPA | 9 |
| Detection | 9 |
| Novartis | 9 |
| HR | 9 |
| People | 9 |
| Hospitals | 9 |
| Wisconsin | 9 |
| San | 9 |
| SAS | 9 |
| lopinavir | 9 |
| Parainfluenza | 9 |
| PaO | 9 |
| October | 9 |
| IV | 9 |
| Data | 8 |
| July | 8 |
| Illness | 8 |
| Hospitalized | 8 |
| Government | 8 |
| Global | 8 |
| F | 8 |
| European | 8 |
| Diagnosis | 8 |
| BAS²IC | 8 |
| Cov-2 | 8 |
| Community | 8 |
| Clinic | 8 |
| COVID | 8 |
| BAMC | 8 |
| Americans | 8 |
| Air | 8 |
| Korea | 8 |
| Kong | 8 |
| Tocilizumab | 8 |
| LRTI | 8 |
| Thailand | 8 |
| List | 8 |
| teno | 8 |
| ofid | 8 |
| meta | 8 |
| bocavirus | 8 |
| WHO | 8 |
| USA | 8 |
| ≥1:40 | 8 |
| hemophagocytic | 8 |
| State | 8 |
| Pneumonia | 8 |
| Pathogen | 8 |
| PTB | 8 |
| Mediterranean | 8 |
| MSF | 8 |
| M. | 8 |
| September | 8 |
| Guangdong | 7 |
| Fisher | 7 |
| Foundation | 7 |
| France | 7 |
| GMR | 7 |
| IVIG | 7 |
| H3N2 | 7 |
| HA | 7 |
| IDV | 7 |
| Djibouti | 7 |
| EHR | 7 |
| ANC | 7 |
| Commission | 7 |
| ClinicalTrials.gov | 7 |
| Children | 7 |
| COV-2 | 7 |
| Brigham | 7 |
| Adults | 7 |
| Adenovirus | 7 |
| Ad | 7 |
| Institutes | 7 |
| 8) | 7 |
| Impact | 7 |
| Hong | 7 |
| Li | 7 |
| Trial | 7 |
| sera | 7 |
| Lung | 7 |
| ritonavir | 7 |
| metagenomic | 7 |
| meningoencephalitis | 7 |
| kg | 7 |
| aOR | 7 |
| West | 7 |
| Virus | 7 |
| Vero | 7 |
| U | 7 |
| Workers | 7 |
| Tacrolimus | 7 |
| Physicians | 7 |
| Montefiore | 7 |
| Sudan | 7 |
| NPV | 7 |
| Network | 7 |
| NL63 | 7 |
| RCT | 7 |
| Risk | 7 |
| SOT | 7 |
| Fig | 6 |
| Infections | 6 |
| InfA | 6 |
| Immunogenicity | 6 |
| Iban | 6 |
| IL-10 | 6 |
| ICV | 6 |
| Hydroxychloroquine | 6 |
| HCT | 6 |
| H | 6 |
| Germany | 6 |
| GenMark | 6 |
| G | 6 |
| Allergy | 6 |
| Ethics | 6 |
| Ct | 6 |
| CoVs | 6 |
| Clinicaltrials.gov | 6 |
| Chi | 6 |
| Chen | 6 |
| Cancer | 6 |
| CSF | 6 |
| Biosystems | 6 |
| BioFire | 6 |
| ARI | 6 |
| Kenya | 6 |
| KDIGO | 6 |
| Applied | 6 |
| King | 6 |
| R. | 6 |
| LL | 6 |
| ≥50 | 6 |
| methylprednisolone | 6 |
| acyclovir | 6 |
| White | 6 |
| URI | 6 |
| UK | 6 |
| Self | 6 |
| Sciences | 6 |
| Science | 6 |
| SHCRC | 6 |
| Rapid | 6 |
| Stewardship | 6 |
| President | 6 |
| NPH | 6 |
| Poisson | 6 |
| Lancet | 6 |
| Luminex | 6 |
| Massachusetts | 6 |
| NC | 6 |
| Ministry | 6 |
| LTEC | 6 |
| North | 6 |
| PPV | 6 |
| Patient | 6 |
| Pearson | 6 |
| Hepatitis | 5 |
| Force | 5 |
| Foster | 5 |
| Gilead | 5 |
| Guide | 5 |
| Hemophagocytic | 5 |
| Maria | 5 |
| IRB | 5 |
| International | 5 |
| L. | 5 |
| MS | 5 |
| Management | 5 |
| Eighth | 5 |
| Environmental | 5 |
| ALT | 5 |
| EIP | 5 |
| E6 | 5 |
| Defense | 5 |
| David | 5 |
| Critical | 5 |
| Centre | 5 |
| CHBAH | 5 |
| CCL3 | 5 |
| Broad | 5 |
| BACKGROUND | 5 |
| Antibody | 5 |
| Analysis | 5 |
| Matthew | 5 |
| ACE2 | 5 |
| Mass | 5 |
| Excel | 5 |
| Microsoft | 5 |
| System | 5 |
| NxTAG | 5 |
| virus | 5 |
| influenza | 5 |
| doc_id | 5 |
| chi | 5 |
| cells/µL | 5 |
| antibiogram | 5 |
| aH5N1c | 5 |
| 5 | |
| Transmission | 5 |
| Time | 5 |
| Technology | 5 |
| TGFβ | 5 |
| TAC | 5 |
| mL | 5 |
| Surface | 5 |
| Randomized | 5 |
| Supply | 5 |
| Outcomes | 5 |
| PIV-1 | 5 |
| PIV-3 | 5 |
| Pathology | 5 |
| Outbreak | 5 |
| Republic | 5 |
| Rhinovirus | 5 |
| School | 5 |
| Observational | 5 |
| SPSS | 5 |
| SPC00394 | 5 |
| Emory | 4 |
| Island | 4 |
| England | 4 |
| Equipment | 4 |
| Exposure | 4 |
| Genomic | 4 |
| H1N2 | 4 |
| HCW | 4 |
| HKU1-positive | 4 |
| HLH-94 | 4 |
| Heart | 4 |
| IUGR | 4 |
| GenBank | 4 |
| Laboratories | 4 |
| James | 4 |
| Joint | 4 |
| K. | 4 |
| Kingdom | 4 |
| KwaZulu | 4 |
| Long | 4 |
| MO | 4 |
| Mann | 4 |
| Marshfield | 4 |
| Microbiology | 4 |
| Molecular | 4 |
| Elizabeth | 4 |
| Emerging | 4 |
| B. | 4 |
| Einstein | 4 |
| Ehrlichia | 4 |
| NK | 4 |
| -Preliminary | 4 |
| AEs | 4 |
| AIDS | 4 |
| APPropriate | 4 |
| ARTI | 4 |
| Abdulaziz | 4 |
| African | 4 |
| Antonio | 4 |
| Approach | 4 |
| Assessment | 4 |
| Authorization | 4 |
| BAL | 4 |
| CD8 | 4 |
| COVID-2019 | 4 |
| Cary | 4 |
| Census | 4 |
| Characteristics | 4 |
| Cohort | 4 |
| Corticosteroid | 4 |
| CrCl | 4 |
| Drive | 4 |
| EUA | 4 |
| Education | 4 |
| Effect | 4 |
| Mozambique | 4 |
| NUS | 4 |
| q4 | 4 |
| Studies | 4 |
| Suppl | 4 |
| Susan | 4 |
| Systems | 4 |
| TMH | 4 |
| TT | 4 |
| TX | 4 |
| Team | 4 |
| Testing | 4 |
| Tool | 4 |
| Vaccine | 4 |
| Whitney | 4 |
| Wong | 4 |
| Zika | 4 |
| azithromycin | 4 |
| bp | 4 |
| disease | 4 |
| drivethrough | 4 |
| eSensor | 4 |
| east | 4 |
| pancytopenia | 4 |
| q1 | 4 |
| rRT | 4 |
| ° | 4 |
| µM | 4 |
| Natal | 4 |
| Suffolk | 4 |
| Training | 4 |
| Student | 4 |
| Protective | 4 |
| Nicole | 4 |
| Nitazoxanide | 4 |
| Statistical | 4 |
| PBPK | 4 |
| PDAID | 4 |
| PHQ-9 | 4 |
| Pacific | 4 |
| Personal | 4 |
| Petersdorf | 4 |
| Pneumocystis | 4 |
| Preparedness | 4 |
| Prevalence | 4 |
| P | 4 |
| Quality | 4 |
| Seqirus | 4 |
| RIH | 4 |
| Spain | 4 |
| Software | 4 |
| Services | 4 |
| Southeast | 4 |
| Seattle | 4 |
| S1 | 4 |
| Roche | 4 |
| Response | 4 |
| Greater | 3 |
| FAS | 3 |
| Grant | 3 |
| Gothenburg | 3 |
| Guo | 3 |
| GlaxoSmithKline | 3 |
| Ghana | 3 |
| Gault | 3 |
| GS-5734 | 3 |
| Feb | 3 |
| Factors | 3 |
| Early | 3 |
| Executive | 3 |
| Evaluation | 3 |
| Erin | 3 |
| Ehrlichiosis | 3 |
| Echovirus | 3 |
| Dx | 3 |
| Discovery | 3 |
| Director | 3 |
| Diego | 3 |
| Diagnostics | 3 |
| Helsinki | 3 |
| Harvard | 3 |
| A.C. | 3 |
| Henter | 3 |
| Huang | 3 |
| Dexamethasone | 3 |
| MD | 3 |
| MAS | 3 |
| MA | 3 |
| Lumpur | 3 |
| Lopinavir | 3 |
| Local | 3 |
| Lackland | 3 |
| LDH | 3 |
| Kuala | 3 |
| Kit | 3 |
| Journal | 3 |
| Jason | 3 |
| Jan | 3 |
| Investigational | 3 |
| Internal | 3 |
| Information | 3 |
| Ill | 3 |
| IRR | 3 |
| ILI | 3 |
| IDSA | 3 |
| Diagnostic | 3 |
| Boston | 3 |
| Declaration | 3 |
| CD4 | 3 |
| MOs | 3 |
| Bio | 3 |
| Base | 3 |
| Bangladesh | 3 |
| BD | 3 |
| Associated | 3 |
| Assay | 3 |
| Antimicrobial | 3 |
| Antibodies | 3 |
| Anne | 3 |
| An | 3 |
| Alignment | 3 |
| Albert | 3 |
| Acute | 3 |
| Academic | 3 |
| Abbott | 3 |
| ALC | 3 |
| A9 | 3 |
| A/ | 3 |
| A. | 3 |
| A(H1N1 | 3 |
| Bronx | 3 |
| CIs | 3 |
| Deborah | 3 |
| CK | 3 |
| Daniel | 3 |
| DD | 3 |
| D | 3 |
| Cyclosporine | 3 |
| Cov | 3 |
| Cooperative | 3 |
| Controlled | 3 |
| Comparison | 3 |
| Common | 3 |
| Cohen | 3 |
| Cockcroft | 3 |
| Co. | 3 |
| Claudia | 3 |
| Chu | 3 |
| Chlamydia | 3 |
| Chinese | 3 |
| Chart | 3 |
| Chain | 3 |
| Case | 3 |
| Camelus | 3 |
| CRRT | 3 |
| MIP-1 | 3 |
| Fellows | 3 |
| Mantel | 3 |
| Transplant | 3 |
| Women | 3 |
| 3 | |
| Washington | 3 |
| View | 3 |
| Vaccines | 3 |
| VRTI | 3 |
| Universal | 3 |
| URTI | 3 |
| UNL | 3 |
| Trials | 3 |
| Tract | 3 |
| Y. | 3 |
| Torque | 3 |
| Thomas | 3 |
| Test | 3 |
| TTP | 3 |
| TGF | 3 |
| Switzerland | 3 |
| Survey | 3 |
| Surveillance | 3 |
| Superscript | 3 |
| Stefano | 3 |
| Wu | 3 |
| Yao | 3 |
| Statins | 3 |
| p=0,006 | 3 |
| Master | 3 |
| ≥70 | 3 |
| ≥5 | 3 |
| ≥40 | 3 |
| ≥10 | 3 |
| ≤ | 3 |
| −80 | 3 |
| β1b | 3 |
| ± | 3 |
| q3 | 3 |
| mycophenolate | 3 |
| Young | 3 |
| myalgias | 3 |
| mofetil | 3 |
| mm | 3 |
| min | 3 |
| middle | 3 |
| mid | 3 |
| max | 3 |
| interleukin-6 | 3 |
| ehrlichiosis | 3 |
| aOR= | 3 |
| Statistics | 3 |
| doxycycline | 3 |
| Species | 3 |
| Nile | 3 |
| Post | 3 |
| Physician | 3 |
| Package | 3 |
| PTLD | 3 |
| POC | 3 |
| PIV-4 | 3 |
| PIV-2 | 3 |
| P. | 3 |
| Office | 3 |
| OHDSI | 3 |
| N95 | 3 |
| Practice | 3 |
| Mycoses | 3 |
| Monitoring | 3 |
| Mongolia | 3 |
| Minnesota | 3 |
| Metagenomic | 3 |
| Meta | 3 |
| Men | 3 |
| Medicare | 3 |
| Soweto | 3 |
| McNemar | 3 |
| Potential | 3 |
| Nassau | 3 |
| Pre | 3 |
| Region | 3 |
| Sheahan | 3 |
| Severe | 3 |
| Products | 3 |
| Service | 3 |
| Sarah | 3 |
| Safety | 3 |
| STROBE | 3 |
| SD | 3 |
| S.A.R. | 3 |
| Robert | 3 |
| SSDI | 3 |
| Rad | 3 |
| Racial | 3 |
| RR | 3 |
| RHDU | 3 |
| RDV | 3 |
| Questionnaire | 3 |
| Recommendations | 3 |
| Prophylaxis | 3 |
| Project | 3 |
| Home | 2 |
| Hua | 2 |
| High | 2 |
| I | 2 |
| Hyalomma | 2 |
| Hung | 2 |
| Huanan | 2 |
| Hopkins | 2 |
| Hospitalizations | 2 |
| Hospitalization | 2 |
| Hon | 2 |
| III | 2 |
| Hilden | 2 |
| II | 2 |
| Implementation | 2 |
| INTERGROWTH-21st | 2 |
| IP | 2 |
| IP-10 | 2 |
| ISF | 2 |
| IU | 2 |
| Iceland | 2 |
| Illumina | 2 |
| Immune | 2 |
| Inc | 2 |
| Index | 2 |
| Informatics | 2 |
| Heather | 2 |
| Insert | 2 |
| Initiative | 2 |
| Helen | 2 |
| Future | 2 |
| Hb | 2 |
| Hajagos | 2 |
| FluxErgy | 2 |
| Investigation | 2 |
| Forecast | 2 |
| Francisco | 2 |
| Frank | 2 |
| Front | 2 |
| Fungal | 2 |
| GA | 2 |
| GISAID | 2 |
| Gene | 2 |
| Georgia | 2 |
| GraphPad | 2 |
| Gray | 2 |
| Gregory | 2 |
| Growth | 2 |
| Görzer | 2 |
| H1 | 2 |
| H3 | 2 |
| H3N6 | 2 |
| HFOD | 2 |
| HIV-1 | 2 |
| HLH-2004 | 2 |
| HMPV | 2 |
| HPIV | 2 |
| HTML | 2 |
| HUS | 2 |
| Haemophagocytic | 2 |
| Interleukin-6 | 2 |
| Magnus | 2 |
| Islander | 2 |
| MSG | 2 |
| Lombardy | 2 |
| Louisiana | 2 |
| Ltd | 2 |
| Ltd. | 2 |
| Lymphodepletion | 2 |
| M.P. | 2 |
| MAGPIX | 2 |
| MEDLINE | 2 |
| METHODS | 2 |
| MF59( | 2 |
| MF59adjuvanted | 2 |
| MIP-1 | 2 |
| MMF | 2 |
| Ma | 2 |
| J. | 2 |
| Magali | 2 |
| Marco | 2 |
| Marine | 2 |
| Mark | 2 |
| Marrow | 2 |
| Mary | 2 |
| Material | 2 |
| McDonald | 2 |
| Measurement | 2 |
| Medicinal | 2 |
| Michael | 2 |
| Michele | 2 |
| Fidelity | 2 |
| Liverpool | 2 |
| Lisa | 2 |
| Linda | 2 |
| Likert | 2 |
| JC | 2 |
| JH | 2 |
| JO | 2 |
| Jane | 2 |
| Janet | 2 |
| Janssen | 2 |
| Javascript | 2 |
| Jeddah | 2 |
| Jennifer | 2 |
| Jerusalem | 2 |
| Jing | 2 |
| John | 2 |
| Johns | 2 |
| Joseph | 2 |
| Joshua | 2 |
| Kaletra | 2 |
| Keywords | 2 |
| Kinetics | 2 |
| Knowledge | 2 |
| L.L. | 2 |
| L.S.M. | 2 |
| LLC | 2 |
| LOS | 2 |
| Lars | 2 |
| Lee | 2 |
| Liat | 2 |
| Liise | 2 |
| Florida | 2 |
| Military | 2 |
| Fellowship | 2 |
| Burden | 2 |
| Antonella | 2 |
| App | 2 |
| Atlanta | 2 |
| Attitudes | 2 |
| Australia | 2 |
| B.S. | 2 |
| Background | 2 |
| Barbara | 2 |
| Basel | 2 |
| Basic | 2 |
| Biologics | 2 |
| Black | 2 |
| Brooke | 2 |
| Bureau | 2 |
| Feasibility | 2 |
| C.I. | 2 |
| CKD | 2 |
| COVID- | 2 |
| COVID-19-Ready | 2 |
| CPE | 2 |
| CSA | 2 |
| CSL | 2 |
| CYP3A4 | 2 |
| Cameroon | 2 |
| Cao | 2 |
| Cape | 2 |
| Central | 2 |
| Challenges | 2 |
| Antiviral | 2 |
| Antigen | 2 |
| Antibiotic | 2 |
| Anti | 2 |
| 3a | 2 |
| 84·9 | 2 |
| 95·6 | 2 |
| 99·3 | 2 |
| ABI | 2 |
| AC | 2 |
| AG | 2 |
| ARF | 2 |
| ARS | 2 |
| AST | 2 |
| Abbo | 2 |
| Acceptability | 2 |
| Ad14 | 2 |
| AdV | 2 |
| Adam | 2 |
| Advanced | 2 |
| Aerosol | 2 |
| Ahmed | 2 |
| Al | 2 |
| Alessandro | 2 |
| Algeria | 2 |
| Ali | 2 |
| Ana | 2 |
| Andrea | 2 |
| Animal | 2 |
| Ann | 2 |
| Anna | 2 |
| Chart.js | 2 |
| Chief | 2 |
| Chlamydophila | 2 |
| De | 2 |
| Development | 2 |
| Discrimination | 2 |
| Disinfectant | 2 |
| Disinfectants | 2 |
| Disinfection | 2 |
| Disparities | 2 |
| Dorothy | 2 |
| Droplet | 2 |
| Dyspnea | 2 |
| ECMO | 2 |
| EORTC | 2 |
| Eastern | 2 |
| Edendale | 2 |
| Edition | 2 |
| Effectiveness | 2 |
| Efficacy | 2 |
| Electronic | 2 |
| Emily | 2 |
| Empiric | 2 |
| Englund | 2 |
| Epidemiologic | 2 |
| Esper | 2 |
| Ethical | 2 |
| Etiology | 2 |
| FL | 2 |
| Fabrication | 2 |
| Facility | 2 |
| Deng | 2 |
| Da | 2 |
| Chloroquine | 2 |
| DIVEIN | 2 |
| Chronic | 2 |
| Chua | 2 |
| Classification | 2 |
| CoV-229E | 2 |
| CoV2 | 2 |
| Collaboration | 2 |
| Collection | 2 |
| Colorado | 2 |
| Command | 2 |
| Comorbidities | 2 |
| Complex | 2 |
| Computing | 2 |
| Conditions | 2 |
| Confalonieri | 2 |
| Consensus | 2 |
| Consortium | 2 |
| Contamination | 2 |
| Contribution | 2 |
| Coordinating | 2 |
| Coronaviruses | 2 |
| Corporation | 2 |
| Corps | 2 |
| Council | 2 |
| Criteria | 2 |
| Cross | 2 |
| D. | 2 |
| D.S. | 2 |
| Michigan | 2 |
| Berlin | 2 |
| Miller | 2 |
| Ying | 2 |
| WI | 2 |
| Wei | 2 |
| Wen | 2 |
| Westmead | 2 |
| Whither | 2 |
| Wilde | 2 |
| Wing | 2 |
| Wipes | 2 |
| Xiao | 2 |
| Xiaoping | 2 |
| Y | 2 |
| YW | 2 |
| Yang | 2 |
| Yonatan | 2 |
| contigs | 2 |
| Yu | 2 |
| Yun | 2 |
| Zafonte | 2 |
| Zhejiang | 2 |
| Zhiwei | 2 |
| anakinra | 2 |
| antibody | 2 |
| antiphospholipid | 2 |
| astrovirus | 2 |
| bacteremias | 2 |
| baloxavir | 2 |
| board | 2 |
| bronchoalveolar | 2 |
| WBC | 2 |
| W. | 2 |
| W | 2 |
| Vice | 2 |
| Tables | 2 |
| Tang | 2 |
| Technologies | 2 |
| Temporal | 2 |
| Tennessee | 2 |
| Tertiary | 2 |
| Texas | 2 |
| Text | 2 |
| Tiing | 2 |
| Timothy | 2 |
| Toh | 2 |
| Town | 2 |
| Transplantation | 2 |
| Turning | 2 |
| 2 | |
| U.S.C. | 2 |
| USSR/90/77 | 2 |
| UW | 2 |
| Update | 2 |
| Upper | 2 |
| Utilization | 2 |
| VP | 2 |
| VP1 | 2 |
| Valentina | 2 |
| Value | 2 |
| Vandermeer | 2 |
| Vertical | 2 |
| census | 2 |
| control | 2 |
| T32 | 2 |
| torquetenovirus | 2 |
| perforin | 2 |
| postprescription | 2 |
| prednisone | 2 |
| q2 | 2 |
| qRT | 2 |
| range | 2 |
| resp | 2 |
| reticularis | 2 |
| review | 2 |
| rhonchi | 2 |
| square | 2 |
| sulfamethoxazole | 2 |
| tacrolimus | 2 |
| trimethoprim | 2 |
| coryza | 2 |
| type | 2 |
| vivo | 2 |
| voriconazole | 2 |
| white | 2 |
| § | 2 |
| ® | 2 |
| × | 2 |
| μg | 2 |
| ≥23 | 2 |
| ≥65 | 2 |
| ≥75 | 2 |
| | 2 |
| Mix | 2 |
| parotitis | 2 |
| p=0.03 | 2 |
| p=0.004 | 2 |
| p=0.001 | 2 |
| covid-19 | 2 |
| coxsackie | 2 |
| cytomegalovirus | 2 |
| cytopenias | 2 |
| dL | 2 |
| data | 2 |
| hypoalbuminemia | 2 |
| hypofibrinogenemia | 2 |
| ie | 2 |
| inperson | 2 |
| interleukin-8 | 2 |
| key | 2 |
| leukocytosis | 2 |
| lymphodepletion | 2 |
| microvasculopathy | 2 |
| mmHg | 2 |
| msLRTD | 2 |
| multicentre | 2 |
| multiorgan | 2 |
| m² | 2 |
| nitazoxanide | 2 |
| nonrespiratory | 2 |
| nonsevere | 2 |
| nonvaccine | 2 |
| novo | 2 |
| orchitis | 2 |
| p= | 2 |
| TNF | 2 |
| eIND | 2 |
| Systematic | 2 |
| Plan | 2 |
| Palmetto | 2 |
| PanFab | 2 |
| Park | 2 |
| Patricia | 2 |
| Patrick | 2 |
| Paul | 2 |
| Performance | 2 |
| Persistence | 2 |
| Peter | 2 |
| Pharmacists | 2 |
| Phase | 2 |
| Pirofski | 2 |
| Placental | 2 |
| Policy | 2 |
| Q | 2 |
| Polymerase | 2 |
| Population | 2 |
| Pr(diff>0 | 2 |
| Practices | 2 |
| Precision | 2 |
| Pregnancy | 2 |
| Preliminary | 2 |
| Presentation | 2 |
| Prime | 2 |
| Professor | 2 |
| Protection | 2 |
| Provider | 2 |
| Providers | 2 |
| PCT | 2 |
| PB2 | 2 |
| Oseltamivir | 2 |
| Orthopedic | 2 |
| Multiplex | 2 |
| Mortality | 2 |
| Surgeon | 2 |
| Mycoplasma | 2 |
| NCT01766921 | 2 |
| NCT01776541 | 2 |
| NCT02608502 | 2 |
| NHS | 2 |
| NICD | 2 |
| NIPPV | 2 |
| NJ | 2 |
| NPPV | 2 |
| Nasia | 2 |
| Nelfinavir | 2 |
| Netherlands | 2 |
| News | 2 |
| Non | 2 |
| Northern | 2 |
| Nucleic | 2 |
| Number | 2 |
| ORF1ab | 2 |
| Officer | 2 |
| Online | 2 |
| Onset | 2 |
| OpenEpi | 2 |
| Orchitis | 2 |
| Organ | 2 |
| PubMed | 2 |
| Outpatient | 2 |
| Q3 | 2 |
| Sandra | 2 |
| Sara | 2 |
| Schoenfeld | 2 |
| Schwartz | 2 |
| Search | 2 |
| Selection | 2 |
| Seo | 2 |
| Sequencing | 2 |
| Serologic | 2 |
| Settings | 2 |
| Sharing | 2 |
| Sharon | 2 |
| Simulation | 2 |
| Skopicki | 2 |
| Smith | 2 |
| Social | 2 |
| Soft | 2 |
| SpO2 | 2 |
| Specialties | 2 |
| Stata | 2 |
| Statement | 2 |
| Station | 2 |
| Stephen | 2 |
| Steven | 2 |
| Strasbourg | 2 |
| Strategies | 2 |
| QI | 2 |
| Strategy | 2 |
| Supplement | 2 |
| Support | 2 |
| Sanofi | 2 |
| Situation | 2 |
| Sanchez | 2 |
| Roberts | 2 |
| RVP | 2 |
| Qiagen | 2 |
| RVU | 2 |
| RW | 2 |
| Rating | 2 |
| Real | 2 |
| Rebecca | 2 |
| Regional | 2 |
| Reporting | 2 |
| Residency | 2 |
| Responses | 2 |
| Rheumatology | 2 |
| Rhode | 2 |
| Registry | 2 |
| Saltz | 2 |
| QX200 | 2 |
| Ross | 2 |
| Ryan | 2 |
| S.S. | 2 |
| S2 | 2 |
| SAE | 2 |
| SAEs | 2 |
| Sample | 2 |
| Safdar | 2 |
| Sahlgrenska | 2 |
| Samples | 2 |
| Icelandic | 1 |
| IL6R | 1 |
| Identification | 1 |
| Ian | 1 |
| IgA. | 1 |
| Identifier | 1 |
| IQRs | 1 |
| IVD | 1 |
| IU]/mL | 1 |
| IUO | 1 |
| ISHLT | 1 |
| IP000155 | 1 |
| INFb | 1 |
| Ignacio | 1 |
| IgM. | 1 |
| Indonesia | 1 |
| Imact | 1 |
| Imaging | 1 |
| Inhibition | 1 |
| IL-22 | 1 |
| Initial | 1 |
| Infant | 1 |
| Indy | 1 |
| Industry | 1 |
| Ing | 1 |
| Indicators | 1 |
| Incubation | 1 |
| Imputation | 1 |
| Implications | 1 |
| Immunotherapy | 1 |
| Immunosuppression | 1 |
| Immunodeficiency | 1 |
| Immunity | 1 |
| IL-4 | 1 |
| Holly | 1 |
| IL-2 | 1 |
| IL-18 | 1 |
| Houston | 1 |
| House | 1 |
| Host | 1 |
| Honn | 1 |
| Hone | 1 |
| Homeostatic | 1 |
| Holms | 1 |
| Hohenboken | 1 |
| Hock | 1 |
| Hoard | 1 |
| Histopathology | 1 |
| Hinschberger | 1 |
| Insurance | 1 |
| Hilli | 1 |
| Hill | 1 |
| Hu | 1 |
| Hueston | 1 |
| Humans | 1 |
| Hypertext | 1 |
| IL-1 | 1 |
| ID16 | 1 |
| ICUs | 1 |
| ICD10 | 1 |
| IBM | 1 |
| Hypoxia | 1 |
| Hyperinflammatory | 1 |
| Humidity | 1 |
| Hypercytokinemia | 1 |
| Hygiene | 1 |
| Hydrocortisone | 1 |
| Husain | 1 |
| Humphries | 1 |
| Humoral | 1 |
| Initiation | 1 |
| Johnson | 1 |
| Integrative | 1 |
| Jarrah | 1 |
| Jingping | 1 |
| Jingmei | 1 |
| Jindong | 1 |
| Jimenez | 1 |
| Jiao | 1 |
| Jianping | 1 |
| Jian | 1 |
| JiaJian | 1 |
| Jessica | 1 |
| Jesper | 1 |
| Jerome | 1 |
| Jennie | 1 |
| Jen | 1 |
| Jeffrey | 1 |
| Jay | 1 |
| Joan | 1 |
| Joanna | 1 |
| Joanne | 1 |
| Justo | 1 |
| Hii | 1 |
| Kaeuffer | 1 |
| Kadar | 1 |
| Ka | 1 |
| KS | 1 |
| KL2 | 1 |
| Juntao | 1 |
| Jocelyn | 1 |
| Julie | 1 |
| Jovan | 1 |
| Jouberton | 1 |
| Jolene | 1 |
| Johannesburg | 1 |
| Johan | 1 |
| Jawa | 1 |
| Japonica | 1 |
| Interaction | 1 |
| Japanese | 1 |
| Ixodidae | 1 |
| Italian | 1 |
| Issues | 1 |
| Isolation | 1 |
| Islamic | 1 |
| Irvine | 1 |
| Iona | 1 |
| Involvement | 1 |
| Invitrogen | 1 |
| Investigating | 1 |
| Interventions | 1 |
| Intervention | 1 |
| Internet | 1 |
| Interim | 1 |
| Interactive | 1 |
| Izzy | 1 |
| JAMA | 1 |
| JBSA | 1 |
| Jamal | 1 |
| Japan | 1 |
| Jansen | 1 |
| Janos | 1 |
| Janies | 1 |
| Jamie | 1 |
| Jambol | 1 |
| Jakie | 1 |
| JBSA)-Lackland | 1 |
| Jaehnig | 1 |
| Jad | 1 |
| Jacqueline | 1 |
| JZ | 1 |
| JX | 1 |
| JSF | 1 |
| Hilary | 1 |
| Fuchun | 1 |
| Higashi | 1 |
| Ganzon | 1 |
| Genmark | 1 |
| Geneious | 1 |
| GeneWiz | 1 |
| Gelins | 1 |
| Gayen | 1 |
| Gautret | 1 |
| Gauteng | 1 |
| Gaunt | 1 |
| Gatta | 1 |
| Gateway | 1 |
| Gasparini | 1 |
| Garland | 1 |
| Gardner | 1 |
| Garcia | 1 |
| Garbino | 1 |
| Genome | 1 |
| Genomics | 1 |
| Geocoder | 1 |
| Glo | 1 |
| Gomes | 1 |
| Goldberg | 1 |
| Goh | 1 |
| GmbH | 1 |
| Glucocorticoids | 1 |
| Glucocorticoid | 1 |
| Gilroy | 1 |
| Geocoding | 1 |
| Gil | 1 |
| Ghaleb | 1 |
| Germ | 1 |
| Gerdt | 1 |
| Geospatial | 1 |
| George | 1 |
| Gao | 1 |
| Gancher | 1 |
| Hieng | 1 |
| Gan | 1 |
| Foschino | 1 |
| Forum2020 | 1 |
| Fortythree | 1 |
| Forty | 1 |
| Fort | 1 |
| Forces | 1 |
| Focus | 1 |
| Fluxergy | 1 |
| Fluid | 1 |
| Fluconazole | 1 |
| FluView | 1 |
| Flu | 1 |
| Florette | 1 |
| Flanigan | 1 |
| Fishman | 1 |
| Foundations | 1 |
| Francesco | 1 |
| Franklin | 1 |
| GBA | 1 |
| Gallagher | 1 |
| Galilee | 1 |
| Galidesivir | 1 |
| Gadiel | 1 |
| Gaccione | 1 |
| GLaMOR | 1 |
| G6PD | 1 |
| François | 1 |
| Förderkreis | 1 |
| Fund | 1 |
| Kalligeros | 1 |
| Fries | 1 |
| Friday | 1 |
| Frey | 1 |
| Gong | 1 |
| Gonorrhea | 1 |
| Gonzalez | 1 |
| Good | 1 |
| Hannah | 1 |
| Hani | 1 |
| Hand | 1 |
| Halland | 1 |
| Hall | 1 |
| Halima | 1 |
| Haenszel | 1 |
| Hadassah | 1 |
| HSV | 1 |
| HR=0.29 | 1 |
| HMIS | 1 |
| HKU | 1 |
| HIV)-Infected | 1 |
| HELLP | 1 |
| HCV | 1 |
| Hansmann | 1 |
| Hao | 1 |
| Harari | 1 |
| Heejung | 1 |
| Hessler | 1 |
| Herzchirurgie | 1 |
| Hertfordshire | 1 |
| Hercules | 1 |
| Hemophagocytosis | 1 |
| Hematologic | 1 |
| Healthy | 1 |
| Hart | 1 |
| Hazards | 1 |
| Hazardous | 1 |
| Hazard | 1 |
| Haywood | 1 |
| Hassan | 1 |
| Hashem | 1 |
| HCG | 1 |
| HAI | 1 |
| H3N8 | 1 |
| Great | 1 |
| Groome | 1 |
| Griscelli | 1 |
| Griffel | 1 |
| Gretchen | 1 |
| Grein | 1 |
| Greigert | 1 |
| Grants | 1 |
| Guangming | 1 |
| Grade | 1 |
| Grad | 1 |
| Gottberg | 1 |
| Gothamist | 1 |
| Gorse | 1 |
| Goodwin | 1 |
| Guan | 1 |
| Guatemala | 1 |
| H1N1v | 1 |
| Guzmán | 1 |
| H1N1pdm09 | 1 |
| H1N1)pdm09 | 1 |
| H02AB04 | 1 |
| H. | 1 |
| Götaland | 1 |
| Gynecology | 1 |
| Guillain | 1 |
| Guelsys | 1 |
| Guilford | 1 |
| Guidelli | 1 |
| Guideline | 1 |
| Guidance | 1 |
| Guibone | 1 |
| Guerrero | 1 |
| Kahn | 1 |
| Luca | 1 |
| Kalogeropoulos | 1 |
| Manua | 1 |
| Markos | 1 |
| Market | 1 |
| Markelz | 1 |
| Mario | 1 |
| Marietjie | 1 |
| Marguerite | 1 |
| Margrit | 1 |
| Marcos | 1 |
| Marcia | 1 |
| Marcello | 1 |
| Marcella | 1 |
| Marburg | 1 |
| Mara | 1 |
| Mapulaneng | 1 |
| Map | 1 |
| Markup | 1 |
| Martha | 1 |
| Marthi | 1 |
| Materials | 1 |
| Mayo | 1 |
| Max | 1 |
| Matteo | 1 |
| Matikwana | 1 |
| Mathematical | 1 |
| Maternal | 1 |
| Match | 1 |
| Martin | 1 |
| Massimiliano | 1 |
| Marzano | 1 |
| Maryland | 1 |
| Martinot | 1 |
| Martino | 1 |
| Martina | 1 |
| Manuel | 1 |
| Mansour | 1 |
| MeSH | 1 |
| Mannheim | 1 |
| MacDougall | 1 |
| Mab114 | 1 |
| MT | 1 |
| MSDS | 1 |
| MSD | 1 |
| MRD | 1 |
| MR | 1 |
| MPH | 1 |
| MPFB | 1 |
| MM | 1 |
| MK2 | 1 |
| MIT | 1 |
| MIRACLE | 1 |
| MIQE | 1 |
| MGH | 1 |
| Macias | 1 |
| Macrophage | 1 |
| Madaline | 1 |
| Maintenance | 1 |
| Manhattan | 1 |
| Malope | 1 |
| Mallipattu | 1 |
| Mallinson | 1 |
| Maliszewski | 1 |
| Malay | 1 |
| Magro | 1 |
| Maddocks | 1 |
| Magnusson | 1 |
| MagnaPure | 1 |
| Magaret | 1 |
| MagNA | 1 |
| Madin | 1 |
| Madhi | 1 |
| McCreary | 1 |
| Measures | 1 |
| MF59-Adjuvanted | 1 |
| Moffit | 1 |
| Multicenter | 1 |
| Mulhouse | 1 |
| Mukerji | 1 |
| Mpumalanga | 1 |
| Moyes | 1 |
| Mother | 1 |
| Morin | 1 |
| Mootien | 1 |
| Mooso | 1 |
| Moody | 1 |
| Montico | 1 |
| Montalvo | 1 |
| Monocyte | 1 |
| Mondoni | 1 |
| Monday | 1 |
| Multiplexed | 1 |
| Multivariable | 1 |
| Multivariate | 1 |
| N. | 1 |
| NCT01610245 | 1 |
| NCT01034254 | 1 |
| NCI | 1 |
| NCBI | 1 |
| NATs | 1 |
| N.K | 1 |
| Myomo | 1 |
| Munjal | 1 |
| Mylonakis | 1 |
| Mylona | 1 |
| Mycobacterium | 1 |
| Mycobacteria | 1 |
| Murray | 1 |
| Murkey | 1 |
| Mojares | 1 |
| Models | 1 |
| Mechanisms | 1 |
| Modeling | 1 |
| Mental | 1 |
| Meningoencephalitis | 1 |
| Meningitis | 1 |
| Menglong | 1 |
| Memorial | 1 |
| Memar | 1 |
| Melanie | 1 |
| Melanau | 1 |
| Meier | 1 |
| Meek | 1 |
| Meece | 1 |
| Mee | 1 |
| Meduri | 1 |
| Medimmune | 1 |
| Medicaid | 1 |
| Merck | 1 |
| Methodist | 1 |
| Methods | 1 |
| Millwood | 1 |
| Model | 1 |
| Mobile | 1 |
| Mitigation | 1 |
| Miriam | 1 |
| Minnesfond | 1 |
| Mini | 1 |
| Millennium | 1 |
| MetroHealth | 1 |
| Mild | 1 |
| Midwest | 1 |
| Michelle | 1 |
| Micaela | 1 |
| Meyer | 1 |
| Mexico | 1 |
| MGB-3′ | 1 |
| MERS)-CoV | 1 |
| Kanesa | 1 |
| Kok | 1 |
| LC | 1 |
| LASSO | 1 |
| LA | 1 |
| Kymriah | 1 |
| Kwang | 1 |
| Kuypers | 1 |
| Kuritzkes | 1 |
| Kurc | 1 |
| Kupffer | 1 |
| Kuonza | 1 |
| Kueh | 1 |
| Kuching | 1 |
| Kremer | 1 |
| Krefeld | 1 |
| Koraishy | 1 |
| LG | 1 |
| LOQ | 1 |
| LS | 1 |
| Lakes | 1 |
| Larkin | 1 |
| Larissa | 1 |
| Large | 1 |
| Lanka | 1 |
| Lanini | 1 |
| Language | 1 |
| Laidler | 1 |
| La | 1 |
| Lai | 1 |
| Lactation | 1 |
| Lacedonia | 1 |
| Labuhn | 1 |
| Labs | 1 |
| Laboratoriemedicin | 1 |
| Kolmogorov | 1 |
| Klerksdorp | 1 |
| Lassa | 1 |
| Klausner | 1 |
| Kaushansky | 1 |
| Katz | 1 |
| Katrina | 1 |
| Katrin | 1 |
| Kathleen | 1 |
| Katherine | 1 |
| Katelyn | 1 |
| Kassala | 1 |
| Karra | 1 |
| Karen | 1 |
| Kardiologie | 1 |
| Kara | 1 |
| Kaplan | 1 |
| Kanwar | 1 |
| Kansas | 1 |
| Kemp | 1 |
| Kerri | 1 |
| Kerry | 1 |
| Kiamanesh | 1 |
| Kittel | 1 |
| Kirley | 1 |
| Kim | 1 |
| Kiley | 1 |
| Kieke | 1 |
| Kidney | 1 |
| Khoury | 1 |
| Kettering | 1 |
| Khattab | 1 |
| Khatry | 1 |
| Khai | 1 |
| Kgokong | 1 |
| Key | 1 |
| Kevin | 1 |
| Larry | 1 |
| Last | 1 |
| ME | 1 |
| Little | 1 |
| Luisi | 1 |
| Luebeck | 1 |
| Lucio | 1 |
| Lucernoni | 1 |
| First | 1 |
| Lott | 1 |
| Lothian | 1 |
| Loss | 1 |
| Los | 1 |
| Longitudinal | 1 |
| London | 1 |
| Logistics | 1 |
| Locations | 1 |
| Loan | 1 |
| Liza | 1 |
| Luiza | 1 |
| Lundin | 1 |
| Luther | 1 |
| MAC | 1 |
| MCP-3 | 1 |
| MCP | 1 |
| MC | 1 |
| MBBS | 1 |
| MB | 1 |
| MAP>90mmHg | 1 |
| M4-RT | 1 |
| Luzzi | 1 |
| M.H. | 1 |
| M.D. | 1 |
| Lymphopenia | 1 |
| Lymphohistiocytosis | 1 |
| Lyme | 1 |
| Lyla | 1 |
| Liu | 1 |
| Linghua | 1 |
| Late | 1 |
| Lingham | 1 |
| Lepak | 1 |
| Lenexa | 1 |
| Lei | 1 |
| Legionella | 1 |
| Legends | 1 |
| Lefebvre | 1 |
| Led | 1 |
| Lecronier | 1 |
| Learning | 1 |
| LeClerq | 1 |
| LeBoeuf | 1 |
| Lazarus | 1 |
| Laxman | 1 |
| Laura | 1 |
| Lau | 1 |
| Lessons | 1 |
| Letter | 1 |
| Levin | 1 |
| Limited | 1 |
| Ling | 1 |
| Lineages | 1 |
| Line | 1 |
| Lindholm | 1 |
| Lindh | 1 |
| Lin | 1 |
| Lim | 1 |
| Liang | 1 |
| Lily | 1 |
| Lilia | 1 |
| Life | 1 |
| Licastro | 1 |
| Liaocheng | 1 |
| Liao | 1 |
| Fishers | 1 |
| Digital | 1 |
| Findings | 1 |
| Bai | 1 |
| Beckwith | 1 |
| Beatriz | 1 |
| Bayer | 1 |
| Baumbach | 1 |
| Battle | 1 |
| Basile | 1 |
| Based | 1 |
| Barré | 1 |
| Baricitinib | 1 |
| Barbaro | 1 |
| Baragwanath | 1 |
| Baolin | 1 |
| Bankrupt | 1 |
| Bang | 1 |
| Baldoquin | 1 |
| Becton | 1 |
| Beh | 1 |
| Behavior | 1 |
| Berita | 1 |
| Bill | 1 |
| Bikash | 1 |
| Bigdye | 1 |
| Bidayuh | 1 |
| BiPAP | 1 |
| Bhar | 1 |
| Bennett | 1 |
| Behaviors | 1 |
| Benjamin | 1 |
| Benenson | 1 |
| Belongia | 1 |
| Belinda | 1 |
| Beijing | 1 |
| Beigel | 1 |
| Bailey | 1 |
| Bacteria | 1 |
| Biocryst | 1 |
| Babatyi | 1 |
| Avalos | 1 |
| Automatic | 1 |
| Autoimmunity | 1 |
| Authorities | 1 |
| Austria | 1 |
| Austin | 1 |
| AusDiagnostics | 1 |
| Aung | 1 |
| Atta | 1 |
| Asymptomatic | 1 |
| Assignment | 1 |
| Assembly | 1 |
| Assays | 1 |
| Assaf | 1 |
| Asian | 1 |
| Average | 1 |
| Avian | 1 |
| Awad | 1 |
| BHQ | 1 |
| BSL-3 | 1 |
| BRIEF | 1 |
| BNP | 1 |
| BK | 1 |
| BIO | 1 |
| BID | 1 |
| BCX4430 | 1 |
| Award | 1 |
| BAL- | 1 |
| B5 | 1 |
| B.V. | 1 |
| Azithromycin | 1 |
| Azhar | 1 |
| Ayla | 1 |
| BioRad | 1 |
| Biodirection | 1 |
| CYP2C8 | 1 |
| Burlington | 1 |
| CD4+:CD8 | 1 |
| CD4(+ | 1 |
| CD-19 | 1 |
| CCS | 1 |
| CCL3/ | 1 |
| CBC | 1 |
| CAMD | 1 |
| CALL | 1 |
| C1000 | 1 |
| C.R.P. | 1 |
| C.K. | 1 |
| Byrd | 1 |
| Buys | 1 |
| Butler | 1 |
| Busby | 1 |
| CD57 | 1 |
| CDM | 1 |
| CE | 1 |
| COVID-19-new | 1 |
| CYP | 1 |
| CTCAE | 1 |
| CR | 1 |
| CPMP | 1 |
| CPAP | 1 |
| COVID-19´s | 1 |
| CMS | 1 |
| CE-2020 | 1 |
| CLL | 1 |
| CLIA | 1 |
| CI:0.47 | 1 |
| CFx96 | 1 |
| CFAR | 1 |
| CEO | 1 |
| Burney | 1 |
| Burgin | 1 |
| Biofire | 1 |
| Brooklyn | 1 |
| Bondaryk | 1 |
| Bolotova | 1 |
| Body | 1 |
| Boards | 1 |
| Bloomberg | 1 |
| Blood | 1 |
| Blake | 1 |
| Biotechnology | 1 |
| Biot | 1 |
| Biosecurity | 1 |
| Biopharma | 1 |
| Biomedical | 1 |
| Biomatters | 1 |
| Biomarkers | 1 |
| Biology | 1 |
| Bonferroni | 1 |
| Bonifazi | 1 |
| Bonuses | 1 |
| Bradley | 1 |
| Brook | 1 |
| Bronchoalveolar | 1 |
| Broadnext10 | 1 |
| Brendish | 1 |
| Breakthrough | 1 |
| Brain | 1 |
| Brad | 1 |
| Bordetella | 1 |
| Bracho | 1 |
| Bowes | 1 |
| Boulware | 1 |
| Boroughs | 1 |
| Borneo | 1 |
| Borjan | 1 |
| Ashley | 1 |
| Ascertainment | 1 |
| Arturo | 1 |
| 98·4 | 1 |
| ANCOVA | 1 |
| ALL | 1 |
| ALFGBG-439391 | 1 |
| ALFGBG-217671 | 1 |
| ALF | 1 |
| AJS | 1 |
| AI131971 | 1 |
| AI007061 | 1 |
| AG000222).Potential | 1 |
| AE | 1 |
| ACS | 1 |
| A1c | 1 |
| A(H5N1 | 1 |
| A(H1N1)pdm09 | 1 |
| 99·8 | 1 |
| ASTCT | 1 |
| ATC | 1 |
| ATG | 1 |
| Abell | 1 |
| Accessed | 1 |
| Access | 1 |
| Acceava | 1 |
| Acari | 1 |
| Academy | 1 |
| Abujamel | 1 |
| Abdulrahman | 1 |
| AUROC | 1 |
| Abdullah | 1 |
| Abbasi | 1 |
| Ab | 1 |
| Aaron | 1 |
| Aakriti | 1 |
| AV | 1 |
| 99·5 | 1 |
| 90·7 | 1 |
| Armonk | 1 |
| 8ed491247700554c686ae716ce7555ddf4f7f331 | 1 |
| 20.Gates | 1 |
| 182/1188 | 1 |
| 12bc05b6a9ae2d8823f67b0a8200fb7f72c45f9b | 1 |
| 11·7 | 1 |
| 1.44–2.48 | 1 |
| /m | 1 |
| .05 | 1 |
| -Ethics | 1 |
| -Caution | 1 |
| -Case | 1 |
| -80 | 1 |
| -4 | 1 |
| -3 | 1 |
| -2 | 1 |
| NCT02612922 | 1 |
| 200/100 | 1 |
| 2020SY004 | 1 |
| 229E | 1 |
| 40kg | 1 |
| 85·1 | 1 |
| 8.5–10.3 | 1 |
| 7i7122zi | 1 |
| 73·3 | 1 |
| 6kc4hyzo | 1 |
| 55fae020adeec20e62937122cfca189e4bcd628d | 1 |
| 30mL | 1 |
| 251/400 | 1 |
| 30cde6802534c773c00129164f762dadc834b95b | 1 |
| 3.8.2 | 1 |
| 3.0 | 1 |
| 3- | 1 |
| 2xUNL | 1 |
| 2c0813f50214197ccbeae857bb05217ade8aae82 | 1 |
| Accession | 1 |
| Accessory | 1 |
| Accountability | 1 |
| Aceh | 1 |
| Andrews | 1 |
| Andersson | 1 |
| Anatomical | 1 |
| Amrin | 1 |
| Ammonium | 1 |
| Amin | 1 |
| Amendments | 1 |
| Amelia | 1 |
| Amanda | 1 |
| Amalia | 1 |
| Alzahrani | 1 |
| Alvarez | 1 |
| Alvarado | 1 |
| Although | 1 |
| Alsaaidi | 1 |
| Angeles | 1 |
| Anhui/01/2005(H5N1 | 1 |
| Annalisa | 1 |
| Aragon | 1 |
| Arkansas | 1 |
| Aridi | 1 |
| Arena | 1 |
| Area | 1 |
| Archuleta | 1 |
| Aran | 1 |
| Arabi | 1 |
| Antigenically | 1 |
| Application | 1 |
| Appendix | 1 |
| Anwar | 1 |
| Anubhav | 1 |
| Antoinette | 1 |
| Antoine | 1 |
| Alpana | 1 |
| Allostatic | 1 |
| Allocation | 1 |
| Adaptation | 1 |
| Advisory | 1 |
| Advance | 1 |
| Adult | 1 |
| Adriane | 1 |
| Adolescents | 1 |
| Address | 1 |
| Ad4 | 1 |
| Afar | 1 |
| Action | 1 |
| Act | 1 |
| Across | 1 |
| Acquired | 1 |
| Achim | 1 |
| Achilles | 1 |
| Aeromonas | 1 |
| Aff | 1 |
| All | 1 |
| Akria | 1 |
| Alghamdi | 1 |
| Alexander | 1 |
| Alejandra | 1 |
| Alberto | 1 |
| Alaska | 1 |
| Alamari | 1 |
| Akerblom | 1 |
| Aflunov | 1 |
| Airway | 1 |
| Ahmad | 1 |
| Aguirre | 1 |
| Agreement | 1 |
| Agency | 1 |
| Age | 1 |
| CYP-3A4 | 1 |
| CYP2D6 | 1 |
| Finance | 1 |
| Dose | 1 |
| EBV- | 1 |
| EBNA1 | 1 |
| EB3 | 1 |
| E.S. | 1 |
| D’Agaro | 1 |
| Dysregulation | 1 |
| Dynamics | 1 |
| Dynamic | 1 |
| Dwyer | 1 |
| Dutch | 1 |
| Durham | 1 |
| Dulin | 1 |
| Du | 1 |
| Drs | 1 |
| Dromedary | 1 |
| ECMAScript | 1 |
| EDs | 1 |
| EIDs | 1 |
| Edward | 1 |
| Eleanor | 1 |
| ElMINDA | 1 |
| El | 1 |
| Ehrlichioses | 1 |
| Eglis | 1 |
| Effective | 1 |
| Eduard | 1 |
| EMR | 1 |
| Edmund | 1 |
| Ebrahim | 1 |
| Easy | 1 |
| EPI_ISL_407893 | 1 |
| EPI | 1 |
| EORTC/ | 1 |
| Dosing | 1 |
| Doris | 1 |
| Enago | 1 |
| Dong | 1 |
| Deland | 1 |
| Dejan | 1 |
| Deepika | 1 |
| Debt | 1 |
| Deaths | 1 |
| Death | 1 |
| Dayong | 1 |
| Dawood | 1 |
| Davì | 1 |
| Davis | 1 |
| Davey | 1 |
| Database | 1 |
| Darunavir | 1 |
| Darius | 1 |
| Darby | 1 |
| Delmis | 1 |
| Demand | 1 |
| Democratic | 1 |
| Distribution | 1 |
| Donato | 1 |
| Dominic | 1 |
| Dolinski | 1 |
| DoD | 1 |
| Division | 1 |
| Disulfiram | 1 |
| Distress | 1 |
| Dermatology | 1 |
| Disasters | 1 |
| Dimitrios | 1 |
| Dickinson | 1 |
| Dhaliwal | 1 |
| Detroit | 1 |
| Derrick | 1 |
| Eleftherios | 1 |
| Engel | 1 |
| Caballero | 1 |
| Fabacher | 1 |
| Fatal | 1 |
| Farmakiotis | 1 |
| Far | 1 |
| Fantin | 1 |
| Fangkun | 1 |
| Fangfei | 1 |
| Fang | 1 |
| False | 1 |
| Fair | 1 |
| Failure | 1 |
| Fafi | 1 |
| Fadi | 1 |
| Facts | 1 |
| Fact | 1 |
| Facing | 1 |
| Fatalities | 1 |
| Fatemeh | 1 |
| Fatt | 1 |
| Fever | 1 |
| Fighting | 1 |
| FigTree | 1 |
| Fiftythree | 1 |
| Fieldhouse | 1 |
| Fibrotic | 1 |
| Fibrosis | 1 |
| Fetal | 1 |
| Favipiravir | 1 |
| Feske | 1 |
| Fengxia | 1 |
| Feng | 1 |
| Female | 1 |
| Fellowships | 1 |
| Fellow | 1 |
| 1 | |
| FVC | 1 |
| English | 1 |
| FUNDING | 1 |
| Estimation | 1 |
| Estimates | 1 |
| Escherichia | 1 |
| Esam | 1 |
| Eritrea | 1 |
| Erik | 1 |
| Eric | 1 |
| Era | 1 |
| Equine | 1 |
| Equatorial | 1 |
| Equations | 1 |
| Epididymo | 1 |
| Epidemic | 1 |
| Epic | 1 |
| Enterobacter | 1 |
| Ethiopia | 1 |
| Ethnicity | 1 |
| Etoposide | 1 |
| Extended | 1 |
| FS | 1 |
| FK506 | 1 |
| FEV1 | 1 |
| FDA)-approval | 1 |
| FBS | 1 |
| Eyriey | 1 |
| Exposures | 1 |
| Euroimmun | 1 |
| Experience | 1 |
| Excellence | 1 |
| Evolution | 1 |
| Event | 1 |
| Evangelia | 1 |
| Europe | 1 |
| Danion | 1 |
| Danilo | 1 |
| Dane | 1 |
| Challenge | 1 |
| Chemokines | 1 |
| Chemical | 1 |
| Chelsea | 1 |
| Cheesan | 1 |
| Chediak | 1 |
| Chaves | 1 |
| Chaudhri | 1 |
| Charting | 1 |
| Charlotte | 1 |
| Charles | 1 |
| Charitable | 1 |
| Characterization | 1 |
| Chao | 1 |
| Chanthavanich | 1 |
| Channel | 1 |
| Cheng | 1 |
| Chenghui | 1 |
| Cheryl | 1 |
| Cho | 1 |
| Christopher | 1 |
| Christine | 1 |
| Christensen | 1 |
| Chris | 1 |
| Choice | 1 |
| Choi | 1 |
| Chiu | 1 |
| Chicago | 1 |
| Chitneni | 1 |
| Ching | 1 |
| Chin | 1 |
| Chimeric | 1 |
| Child | 1 |
| Chilblain | 1 |
| Chang | 1 |
| Chalid | 1 |
| Damien | 1 |
| Chains | 1 |
| Carmack | 1 |
| Carlson | 1 |
| Caribbean | 1 |
| Cardinal | 1 |
| Capital | 1 |
| Candida | 1 |
| Campus | 1 |
| Caminati | 1 |
| Camels | 1 |
| Camelids | 1 |
| Cambridge | 1 |
| Calvin | 1 |
| Caledonia | 1 |
| Cai | 1 |
| Cador | 1 |
| Carmela | 1 |
| Carole | 1 |
| Carolina | 1 |
| Cellai | 1 |
| Chained | 1 |
| Chaillon | 1 |
| Cernoch | 1 |
| Cerner | 1 |
| Cerebrospinal | 1 |
| Centanni | 1 |
| Cell | 1 |
| Caroline | 1 |
| Ceftriaxone | 1 |
| Cases | 1 |
| Casarin | 1 |
| Casals | 1 |
| Casadevall | 1 |
| Carter | 1 |
| Chuet | 1 |
| Chunliang | 1 |
| Chylek | 1 |
| Cincinnati | 1 |
| Curricula | 1 |
| Cunninghamella | 1 |
| CumulativeNumberH5N1cases.pdf?ua=1 | 1 |
| Culture | 1 |
| Cropper | 1 |
| Critically | 1 |
| Craig | 1 |
| Coxsackie | 1 |
| Covariates | 1 |
| Country | 1 |
| Counties | 1 |
| Cote | 1 |
| Cosimi | 1 |
| Corrections | 1 |
| Corp. | 1 |
| Curt | 1 |
| Cybulski | 1 |
| Cycle | 1 |
| DNAemia | 1 |
| Daily | 1 |
| Daejeon | 1 |
| DSM | 1 |
| DR | 1 |
| DP2AI144244 | 1 |
| DNR | 1 |
| DL | 1 |
| Cycler | 1 |
| DART | 1 |
| D.J. | 1 |
| Czarina | 1 |
| Cytomegalovirus | 1 |
| Cytokines | 1 |
| Cytokine | 1 |
| Coronaviridae | 1 |
| Cornelius | 1 |
| Core | 1 |
| Clopper | 1 |
| Codes | 1 |
| Coagulopathy | 1 |
| CoV. | 1 |
| CoV-19 | 1 |
| Clubs | 1 |
| Clorox | 1 |
| Clinton | 1 |
| Committees | 1 |
| ClinicalTrials | 1 |
| Cleveland | 1 |
| Claps | 1 |
| ClapforNHS | 1 |
| Cities | 1 |
| Circulation | 1 |
| Colmar | 1 |
| Communicable | 1 |
| Context | 1 |
| Congo | 1 |
| Contact | 1 |
| Consultation | 1 |
| Considerations | 1 |
| Consecutive | 1 |
| Connecticut | 1 |
| Conigliaro | 1 |
| Concetta | 1 |
| Communication | 1 |
| Computer | 1 |
| Computational | 1 |
| Comprehensive | 1 |
| Composition | 1 |
| Company | 1 |
| Communities | 1 |
| NCT02266628 | 1 |
| Torelli | 1 |
| NCT02957136 | 1 |
| Zabreen | 1 |
| Zung | 1 |
| Zucchetto | 1 |
| Zou | 1 |
| Zoom | 1 |
| Zlotorzynska | 1 |
| Ziwei | 1 |
| Zip | 1 |
| Ziang | 1 |
| Zhen | 1 |
| Zhao | 1 |
| Zhang | 1 |
| Zeng | 1 |
| Zenaida | 1 |
| Zealand | 1 |
| Zash | 1 |
| a4cb6f6f690c1367e4a5c7b2ac1292a7283a0368 | 1 |
| a677c82392d5ceb4dc1399f1500761a662bc8aa2 | 1 |
| a6ea21d8e8f97c41b9f69ee6c5d82f5c1a11107b | 1 |
| angiotensin-2 | 1 |
| aplasia | 1 |
| antithymocyte | 1 |
| antineutrophil | 1 |
| antigen | 1 |
| anti | 1 |
| anne | 1 |
| anelloviruses | 1 |
| aHR | 1 |
| america | 1 |
| ageusia | 1 |
| agar | 1 |
| af0768141c00f1317b4fb9c74080d1510de93f32 | 1 |
| administration | 1 |
| adenoviral | 1 |
| Zansky | 1 |
| ZT | 1 |
| arthralgia | 1 |
| ZMapp | 1 |
| Xueliang | 1 |
| XueBiJing | 1 |
| Xu | 1 |
| Xizang | 1 |
| Xilong | 1 |
| Xie | 1 |
| Xiang | 1 |
| XW | 1 |
| X | 1 |
| Worldwide | 1 |
| Work | 1 |
| Woo | 1 |
| Woman | 1 |
| Wolter | 1 |
| Witwatersrand | 1 |
| Xueyuan | 1 |
| Xunxi | 1 |
| Yampoulski | 1 |
| Yoo | 1 |
| Z.M. | 1 |